14-3-3 and aggresome formation Implications in neurodegenerative diseases

被引:24
|
作者
Jia, Baohui [1 ,2 ]
Wu, Yuying [1 ]
Zhou, Yi [1 ]
机构
[1] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA
[2] China Acad Chinese Med Sci, Guanganmen Hosp, Beijing, Peoples R China
关键词
14-3-3; aggresomes; protein misfolding; protein aggregation; chaperones; inclusion bodies; neurodegeneration; PROTEIN-QUALITY CONTROL; MISFOLDED PROTEINS; NEUROFIBRILLARY TANGLES; MOLECULAR CHAPERONES; SELECTIVE AUTOPHAGY; ALZHEIMERS-DISEASE; INCLUSION-BODIES; LEWY BODIES; STRESS; 14-3-3-PROTEINS;
D O I
10.4161/pri.28123
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein misfolding and aggregation underlie the pathogenesis of many neurodegenerative diseases. In addition to chaperone-mediated refolding and proteasomal degradation, the aggresome-macroautophagy pathway has emerged as another defense mechanism for sequestration and clearance of toxic protein aggregates in cells. Previously, the 14-3-3 proteins were shown to be indispensable for the formation of aggresomes induced by mutant huntingtin proteins. In a recent study, we have determined that 14-3-3 functions as a molecular adaptor to recruit chaperone-associated misfolded proteins to dynein motors for transport to aggresomes. This molecular complex involves a dimeric binding of 14-3-3 to both the dynein-intermediate chain (DIC) and an Hsp70 co-chaperone Bcl-2-associated athanogene 3 (BAG3). As 14-3-3 has been implicated in various neurodegenerative diseases, our findings may provide mechanistic insights into its role in managing misfolded protein stress during the process of neurodegeneration.
引用
收藏
页码:173 / 177
页数:5
相关论文
共 50 条
  • [1] Aggresome formation and neurodegenerative diseases: Therapeutic implications
    Olzmann, J. A.
    Li, L.
    Chin, L. S.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2008, 15 (01) : 47 - 60
  • [2] 14-3-3 isoforms in lipid rafts: the role in neurodegenerative diseases
    Houston, N.
    Brechin, C.
    Falconer, H.
    Vigbedor, M.
    Maltas, E.
    Aitken, A.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2010, 113 : 12 - 12
  • [3] 14-3-3 Proteins: Novel Pharmacological Targets in Neurodegenerative Diseases
    Pair, F. Sanders
    Yacoubian, Talene A.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2021, 42 (04) : 226 - 238
  • [4] Dysregulation of 14-3-3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology
    McFerrin, Michael B.
    Chi, Xiaofei
    Cutter, Gary
    Yacoubian, Talene A.
    [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2017, 4 (07): : 466 - 477
  • [5] Physiological Consequences of Targeting 14-3-3 and Its Interacting Partners in Neurodegenerative Diseases
    Ganne, Akshatha
    Balasubramaniam, Meenakshisundaram
    Mainali, Nirjal
    Atluri, Paavan
    Reis, Robert J. Shmookler J.
    Ayyadevara, Srinivas
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
  • [6] The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation
    Burnett, BG
    Pittman, RN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (12) : 4330 - 4335
  • [7] Novel brain 14-3-3 interacting proteins involved in neurodegenerative disease
    Mackie, S
    Aitken, A
    [J]. FEBS JOURNAL, 2005, 272 (16) : 4202 - 4210
  • [8] Dysregulation of 14-3-3 zeta contributes to Huntington diseases
    Chiang, Ming-Chang
    Juo, Chiun-Gung
    Chern, Yijuang
    [J]. NEUROSCIENCE RESEARCH, 2008, 61 : S269 - S269
  • [9] 14-3-3 proteins: an important regulator of autophagy in diseases
    Jia, Haoyuan
    Liang, Zhaofeng
    Zhang, Xu
    Wang, Juanjuan
    Xu, Wenrong
    Qian, Hui
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2017, 9 (11): : 4738 - 4746
  • [10] Downregulation of 14-3-3β and 14-3-3ζ in lesions of psoriasis vulgaris
    Man, X.
    Zhang, X.
    Tang, J.
    Chen, Y.
    Li, H.
    Xu, B.
    Pan, L.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2013, 38 (04) : 390 - 395